Evidera
Seth Walters is a highly skilled research professional currently serving as a Research Associate III at Evidera since January 2021, previously holding the position of Modeling & Simulation Research Associate II. Before joining Evidera, Seth gained valuable experience as a Postdoctoral Research Associate at the University of Pittsburgh School of Medicine from 2016 to 2019, culminating in two first-author peer-reviewed journal articles. As a Graduate Research Assistant and Graduate Teaching Assistant at the University of Pittsburgh from 2011 to 2016, Seth completed numerous projects, contributing to multiple publications and teaching extensive undergraduate courses. Earlier experience includes roles as a Chemistry Tutor at Tutor.com, Graduate Teaching Assistant at Purdue University, and Bioinformatics Database Curator at Procter & Gamble. Seth holds a PhD in Electroanalytical Chemistry from the University of Pittsburgh and a B.S. in Molecular & Cellular Biology from Ohio University.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.